Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$288.68
+3.29%
Mkt Cap $40.46B
Analyst Ratings
Buy
18
Hold
7
Sell
6
Price Target (80 analysts)
$210.67
Range $155.00 – $260.00
Implied Upside
-27.0%
Consensus $210.67 vs current $288.68